Natural killer-cell malignancies: diagnosis and treatment
Author:
Open Access
- 22 September 2005
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 19 (12) , 2186-2194
Abstract
Natural killer (NK)-cell malignancies are uncommon diseases. Previously known as polymorphic reticulosis or angiocentric T-cell lymphomas, they are classified by the World Health Organization as NK/T-cell lymphoma, nasal type and aggressive NK-cell leukemia. They are prevalent in Asia and South America, but exceptionally rare in western countries. Pathologically, NK-cell lymphomas show a polymorphic neoplastic infiltrate with an angioinvasive and angiodestructive pattern. Lymphoma cells are characteristically CD2+, CD56+ and cytoplasmic CD3ɛ+. T-cell receptor gene is germline, and clonal Epstein–Barr virus (EBV) infection is almost invariably. Clinically, they can be divided into nasal, non-nasal, and aggressive lymphoma/leukemia subtypes. Most nasal NK-cell lymphomas present with stage I/II disease, and frontline radiotherapy is the most important key to successful treatment. Many stage I/II patients treated with radiotherapy fail systemically, implying that concomitant chemotherapy may be needed. Chemotherapy is indicated for advanced nasal NK-cell lymphoma, and the non-nasal and aggressive subtypes. However, treatment results are unsatisfactory. High-dose chemotherapy with hematopoietic stem cell transplantation may be beneficial to selected patients. The International Prognostic Index and presentation EBV DNA load is of prognostic significance and may be useful in the stratification of patients for various treatment modalities.Keywords
This publication has 74 references indexed in Scilit:
- Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disordersEuropean Journal of Haematology, 2005
- Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvementJournal of Clinical Pathology, 2005
- Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpointsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein–Barr virus (CAEBV) infection with allogeneic bone marrow transplantationBone Marrow Transplantation, 2003
- Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphomaLeukemia, 2003
- Bone Marrow Involvement by Nasal NK Cell Lymphoma at Diagnosis Is UncommonAmerican Journal of Clinical Pathology, 2001
- Comparative Genomic Hybridization Analysis of Natural Killer Cell Lymphoma/LeukemiaThe American Journal of Pathology, 1999
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- CD56+ NK lymphomas:clinicopathological features and prognosisBritish Journal of Haematology, 1997
- Treatment of Lethal Midline Granuloma Type Nasal T-Cell LymphomaActa Oncologica, 1997